Scipio bioscience

SCIPIO BIOSCIENCE – “single-cell profiling for every benchtop”
Scipio Bioscience develops an innovative, user-friendly, and inexpensive kit enabling life scientists to prepare their own samples for single-cell sequencing.
Scipio Bioscience aims at democratizing single-cell analysis by providing the reference sample preparation tool for every academic and clinical research laboratory.

Press releases

Press
25. February 2020

Scipio bioscience raises €6.0 M Series A financing to develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing

Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6.0 M Series A financing from an international syndicate led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck. The initial shareholders Seventure Partners’ Quadrivum I (Paris, France) and High-Tech Gründerfonds (Bonn, Germany) participated in the capital increase, alongside additional investo
 

Address

Institut du Cerveau et de la Moelle épinière
iPEPS - ICM
47 boulevard de l'hôpital
75013 Paris

In portfolio

15. Nov 2017

Sector

HTGF Manager

 
Dr. Frank Hensel, Principal / Authorized signatory